High-yield reassortant influenza vaccine production virus has a mutation at an HLA-A 2.1-restricted CD8+ CTL epitope on the NS1 protein

Virology

Volumn 259, Issue 1, 1999, Pages 135-140

  Terajima, Masanori ^a   Jameson, Julie ^a   Norman, Joyce E ^a   Cruz, John ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; INFLUENZA VACCINE; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS RNA; VIRUS SIALIDASE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TARGET CELL DESTRUCTION; VACCINE PRODUCTION; VIRUS GENE; VIRUS MUTATION; VIRUS STRAIN;

EID: 0033587313     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9719     Document Type: Article

References (12)

1. Bertoletti A., Sette A., Chisari F. V., Penna A., Levrero M., De Carli M., Fiaccadori F., Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:1994;407-410.
2. + human cytotoxic T lymphocytes. J. Virol. 63:1989;5086-5091.
3. + T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: Bulk culture proliferation, clonal analysis, and precursor frequency determination. J. Virol. 67:1993;5962-5967.
4. Jameson J., Cruz J., Ennis F. A. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J. Virol. 72:1998;8682-8689.
5. Kilbourne E. D. Future influenza vaccines and the use of genetic recombinants. Bull. World Health Org. 41:1969;643-645.
6. Kilbourne E. D. Inactivated influenza vaccines. Plotkin S. A., Mortimer E. A. Jr. Vaccines. 1994;565-581 Saunders, Philadelphia.
7. Klenerman P., Rowland-Jones S., McAdam S., Edwards J., Daenke S., Lalloo D., Koppe B., Rosenberg W., Boyd D., Edwards A., Giangrande P., Phillips R. E., McMichael A. J. Cytotoxic T-cell activity antagonized naturally occurring HIV-1 Gag variants. Nature. 369:1994;403-407.
8. Man S., Newberg M. H., Crotzer V. L., Luckey C. J., Williams N. S., Chen Y., Huczko E. L., Ridge J. P., Engelhard V. H. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. Int. Immunol. 7:1995;597-605.
9. McMichael A. Cytotoxic T lymphocytes specific for influenza virus. Curr. Top. Microbiol. Immunol. 189:1994;75-91.
10. Parker C. E., Gould K. G. Influenza A virus - A model for viral antigen presentation to cytotoxic T lymphocytes. Semin. Virol. 7:1996;61-73.
11. Suarez D. L., Perdue M. L. Multiple alignment comparison of the non-structural genes of influenza A viruses. Virus Res. 54:1998;59-69.
12. Terajima M., Yamaya M., Sekizawa K., Okinaga S., Suzuki T., Yamada N., Nakayama K., Ohrui T., Oshima T., Numazaki Y., Sasaki H. Rhinovirus infection of primary cultures of human tracheal epithelium: Role of ICAM-1 and IL-1beta. Am. J. Physiol. 273:1997;L749-L759.